Insights

  • Date

  • Content Type

  • Reset

White Paper

Science Huddle – SMALL DATA, BIG OUTCOMES

26.01.23
With the reach and impact of biopharma growing exponentially, experts in biotech and the evolving

Blog

The rise of Bayesian statistics in rare disease evidence gathering

16.01.23
Regulators are becoming more open to alternative data sources in the context of rare disease

Blog

Enabling Access Through Innovation – Cell and Gene Therapy in 2023 and Beyond

16.01.23
Dr. Jörg Schneider, Director – Principal Consultant at BioPharma Excellence, previews the opening plenary session

Blog

The next breakthrough: using Cell Therapies to treat solid tumors

1.01.23

By Cori Gorman, Ph.D.

Cell therapy has advanced both in the clinic and in drug approvals. Research is focused on two approaches to...

Blog

What a year! Biopharma Excellence has been easing the path to market for a whole host of advanced therapies and biosimilars

28.11.22
by Dr. Christian K Schneider Head of Biopharma Excellence   As Biopharma Excellence marks its

Blog

The big gene edit: the view from the front line

9.11.22

By Tim Farries, PhD

Reflections on a lively panel debate at the 2022 Cell & Gene Meeting on the